Atrial Fibrillation and Dementia: Pathophysiological Mechanisms and Clinical Implications

被引:5
|
作者
Varrias, Dimitrios [1 ]
Saralidze, Tinatin [1 ]
Borkowski, Pawel [1 ]
Pargaonkar, Sumant [1 ]
Spanos, Michail [2 ]
Bazoukis, George [3 ]
Kokkinidis, Damianos [4 ]
机构
[1] Albert Einstein Coll Med, Jacobi Med Ctr, Dept Med, Bronx, NY 10461 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA
[3] European Univ Cyprus, Sch Med, CY-2404 Nicosia, Cyprus
[4] Yale Univ, Sect Cardiovasc Med, New Haven, CT 06520 USA
关键词
dementia; atrial fibrillation; Alzheimer's; stroke; bleeding; anticoagulation; ANTAGONIST ORAL ANTICOAGULANTS; SILENT CEREBRAL INFARCTIONS; CATHETER ABLATION; COGNITIVE DECLINE; INCIDENT DEMENTIA; LESS DEMENTIA; RISK-FACTOR; STROKE; ASSOCIATION; POPULATION;
D O I
10.3390/biom14040455
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Numerous longitudinal studies suggest a strong association between cardiovascular risk factors and cognitive impairment. Individuals with atrial fibrillation are at higher risk of dementia and cognitive dysfunction, as atrial fibrillation increases the risk of cerebral hypoperfusion, inflammation, and stroke. The lack of comprehensive understanding of the observed association and the complex relationship between these two diseases makes it very hard to provide robust guidelines on therapeutic indications. With this review, we attempt to shed some light on how atrial fibrillation is related to dementia, what we know regarding preventive interventions, and how we could move forward in managing those very frequently overlapping conditions.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Endocrine effects of lithium: Pathophysiological mechanisms and clinical implications
    Manriquez, Fernando
    Mosso, Lorena
    Fardella, Carlos
    REVISTA MEDICA DE CHILE, 2024, 152 (04) : 498 - 507
  • [32] Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications
    Gawalko, Monika
    Agbaedeng, Thomas A.
    Saljic, Arnela
    Mueller, Dominik N.
    Wilck, Nicola
    Schnabel, Renate
    Penders, John
    Rienstra, Michiel
    van Gelder, Isabelle
    Jespersen, Thomas
    Schotten, Ulrich
    Crijns, Harry J. G. M.
    Kalman, Jonathan M.
    Sanders, Prashanthan
    Nattel, Stanley
    Dobrev, Dobromir
    Linz, Dominik
    CARDIOVASCULAR RESEARCH, 2022, 118 (11) : 2415 - 2427
  • [33] Editorial: Pathophysiological and clinical insights for atrial fibrillation/flutter or heart failure
    Lin, Chun
    Liu, Jianfeng
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [34] The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications
    Dobrev, Dobromir
    Voigt, Niels
    Wehrens, Xander H. T.
    CARDIOVASCULAR RESEARCH, 2011, 89 (04) : 734 - 743
  • [35] Extracellular matrix remodeling in atrial fibrosis: Mechanisms and implications in atrial fibrillation
    Pellman, Jason
    Lyon, Robert C.
    Sheikh, Farah
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2010, 48 (03) : 461 - 467
  • [36] Atrial fibrillation and dementia
    Jacobs, Victoria
    Cutler, Michael J.
    Day, John D.
    Bunch, T. Jared
    TRENDS IN CARDIOVASCULAR MEDICINE, 2015, 25 (01) : 44 - 51
  • [37] Atrial Fibrillation and Dementia
    Bunch, T. Jared
    CIRCULATION, 2020, 142 (07) : 618 - 620
  • [38] Atrial Fibrillation and Dementia
    Beekman, Aartjan T. F.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2021, 29 (11): : 1099 - 1100
  • [39] Mitochondria and the Pathophysiological Mechanism of Atrial Fibrillation
    Li, Xinye
    Yang, Xinyu
    Li, Yanda
    Yuan, Mengchen
    Tian, Chao
    Yang, Yihan
    Zhang, Xiaoyu
    Liu, Chao
    Gao, Yonghong
    Liu, Nian
    Shang, Hongcai
    Xing, Yanwei
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (26) : 3055 - 3061
  • [40] Uremic Toxins and Atrial Fibrillation: Mechanisms and Therapeutic Implications
    Yamagami, Fumi
    Tajiri, Kazuko
    Yumino, Dai
    Ieda, Masaki
    TOXINS, 2019, 11 (10)